GeoVax and Emory University to Collaborate on HPV Therapeutic Program for Head and Neck Cancers
July 30, 2018 09:00 ET
|
GeoVax, Inc.
GeoVax Continues Expansion of its MVA-VLP Vaccine Pipeline with Multiple Collaborations in Infectious Disease and Immuno-oncology ATLANTA, GA, July 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc....
GeoVax to Present at the American Society for Virology 2018 Annual Meeting
July 09, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, July 09, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress,...
GeoVax Awarded NIH Grant for Novel Zika Vaccine
May 24, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and...
GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates
May 03, 2018 13:00 ET
|
GeoVax, Inc.
ATLANTA, May 03, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
GeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress
April 05, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, April 05, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, is honored to announce that it won “Best Biotech” at the World...
GeoVax to Present at the 2018 ASM Biothreats Conference
January 31, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Jan. 31, 2018 (GLOBE NEWSWIRE) --
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer, Farshad...
GeoVax to Collaborate with the U.S. Naval Research Laboratory On Development of Lassa Fever Biosensors
December 12, 2017 09:00 ET
|
GeoVax, Inc.
Atlanta, GA, Dec. 12, 2017 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with the U.S. Naval...